
Congress Stock Trades
Every stock trade members of the U.S. House disclose under the STOCK Act, parsed straight from the official Clerk filings. Free, no account needed.
- Trades filed · 30 days
- 319
- Members trading · 90 days
- 48
- Latest filing
- Sep 17, 2026
- Median disclosure delay
- 24 days
Money flow by ticker
Net sellingNet buyingLast 60 days · range midpoints- Nettradesmembers
Most active
Last 90 days
Gilbert Ray Cisneros, Jr.D85 Buy · 57 Sell143$2.3M
April McClain DelaneyD52 Buy · 87 Sell140$6.3M
Kevin HernR8 Buy · 36 Sell47$1.7M
Dan NewhouseR12 Buy · 19 Sell31$248K
David J. TaylorR17 Buy · 9 Sell26$233K
Richard McCormickR1 Buy · 25 Sell26$208K
Scott H. PetersD12 Buy · 10 Sell22$7.0M
Josh GottheimerD13 Buy · 7 Sell20$2.4M
Type
More filters
Party
Owner
Asset
Amount
Traded from
Traded to
Trades
Source: U.S. House Clerk periodic transaction reports| Member | Asset | Type | Owner | Filing | ||||
|---|---|---|---|---|---|---|---|---|
Michael A. RulliROH-6 | Eli Lilly and Company Common Stock | Sell | Self | Jul 1, 2026 | Aug 7, 2026 | 37d | $1K – $15K | PDF ↗ |
Michael A. RulliROH-6 | Eli Lilly and Company Common Stock | Buy | Self | Jan 2, 2026 | Aug 7, 2026 | 217d ! | $1K – $15K | PDF ↗ |
Michael A. RulliROH-6 | Eli Lilly and Company Common Stock | Sell | Self | Dec 2, 2025 | Aug 7, 2026 | 248d ! | $1K – $15K | PDF ↗ |
Dan NewhouseRWA-4 | Eli Lilly and Company Common Stock | Partial sale | Spouse | Jul 10, 2026 | Jul 17, 2026 | 7d | $1K – $15K | PDF ↗ |
Eli Lilly and Company Common Stock | Buy | Self | Jun 10, 2026 | Jul 2, 2026 | 22d | $50K – $100K | PDF ↗ | |
Byron DonaldsRFL-19 | Eli Lilly and Company Common Stock | Buy | Spouse | Apr 2, 2026 | May 13, 2026 | 41d | $1K – $15K | PDF ↗ |
Byron DonaldsRFL-19 | Eli Lilly and Company Common Stock | Buy | Self | Apr 2, 2026 | May 13, 2026 | 41d | $1K – $15K | PDF ↗ |
Eli Lilly and Company Common Stock | Buy | Self | Apr 14, 2026 | May 8, 2026 | 24d | $1K – $15K | PDF ↗ | |
Lizzie FletcherDTX-7 | Eli Lilly and Company Common Stock | Partial sale | Self | Apr 8, 2026 | May 1, 2026 | 23d | $1K – $15K | PDF ↗ |
Eli Lilly and Company Common Stock | Partial sale | Self | Mar 13, 2026 | Apr 7, 2026 | 25d | $1K – $15K | PDF ↗ | |
David J. TaylorROH-2 | Eli Lilly and Company Common Stock | Buy | Self | Feb 26, 2026 | Mar 6, 2026 | 8d | $1K – $15K | PDF ↗ |
David J. TaylorROH-2 | Eli Lilly and Company Common Stock | Sell | Self | Feb 9, 2026 | Feb 20, 2026 | 11d | $1K – $15K | PDF ↗ |
David J. TaylorROH-2 | Eli Lilly and Company Common Stock | Sell | Self | Jan 16, 2026 | Feb 2, 2026 | 17d | $1K – $15K | PDF ↗ |
Julie JohnsonDTX-32 | Eli Lilly and Company Common Stock | Sell | Joint | Dec 18, 2025 | Jan 15, 2026 | 28d | $1K – $15K | PDF ↗ |
David J. TaylorROH-2 | Eli Lilly and Company Common Stock | Sell | Self | Dec 10, 2025 | Dec 19, 2025 | 9d | $1K – $15K | PDF ↗ |
Eli Lilly and Company Common Stock | Buy | Self | Nov 18, 2025 | Dec 15, 2025 | 27d | $1K – $15K | PDF ↗ | |
Julie JohnsonDTX-32 | Eli Lilly and Company Common Stock | Partial sale | Joint | Nov 13, 2025 | Dec 11, 2025 | 28d | $1K – $15K | PDF ↗ |
Val T. HoyleDOR-4 | Eli Lilly and Company Common Stock | Sell | Spouse | Sep 23, 2025 | Oct 10, 2025 | 17d | $1K – $15K | PDF ↗ |
Val T. HoyleDOR-4 | Eli Lilly and Company Common Stock | Partial sale | Spouse | May 6, 2025 | Sep 12, 2025 | 129d ! | $1K – $15K | PDF ↗ |
Val T. HoyleDOR-4 | Eli Lilly and Company Common Stock | Buy | Spouse | Oct 29, 2024 | Sep 12, 2025 | 318d ! | $1K – $15K | PDF ↗ |
Julie JohnsonDTX-32 | Eli Lilly and Company Common Stock | Partial sale | Joint | Aug 14, 2025 | Sep 11, 2025 | 28d | $1K – $15K | PDF ↗ |
David J. TaylorROH-2 | Eli Lilly and Company Common Stock | Buy | Self | Aug 14, 2025 | Sep 2, 2025 | 19d | $1K – $15K | PDF ↗ |
David J. TaylorROH-2 | Eli Lilly and Company Common Stock | Buy | Self | Aug 14, 2025 | Sep 2, 2025 | 19d | $15K – $50K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Eli Lilly and Company Common Stock | Sell | Spouse | May 21, 2025 | Aug 25, 2025 | 96d ! | $1K – $15K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Eli Lilly and Company Common Stock | Buy | Spouse | Apr 23, 2025 | Aug 25, 2025 | 124d ! | $1K – $15K | PDF ↗ |
Lisa C. McClainRMI-9 | Eli Lilly and Company Common Stock | Sell | Spouse | Jul 16, 2025 | Aug 13, 2025 | 28d | $1K – $15K | PDF ↗ |
Lisa C. McClainRMI-9 | Eli Lilly and Company Common Stock | Buy | Spouse | Jul 10, 2025 | Aug 13, 2025 | 34d | $1K – $15K | PDF ↗ |
Lisa C. McClainRMI-9 | Eli Lilly and Company Common Stock | Partial sale | Spouse | Jun 9, 2025 | Aug 13, 2025 | 65d ! | $1K – $15K | PDF ↗ |
Lisa C. McClainRMI-9 | Eli Lilly and Company Common Stock | Buy | Spouse | Dec 11, 2024 | Aug 13, 2025 | 245d ! | $1K – $15K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Eli Lilly and Company Common Stock | Sell | Joint | Jun 3, 2025 | Jul 14, 2025 | 41d | $15K – $50K | PDF ↗ |
Jefferson ShreveRIN-6 | Eli Lilly and Company Common Stock | Sell | Self | May 12, 2025 | Jun 22, 2025 | 41d | $100K – $250K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | May 13, 2025 | Jun 11, 2025 | 29d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Buy | Joint | May 1, 2025 | Jun 11, 2025 | 41d | $1K – $15K | PDF ↗ |
Eli Lilly and Company Common Stock | Partial sale | Self | May 30, 2025 | Jun 6, 2025 | 7d | $1K – $15K | PDF ↗ | |
Marjorie Taylor GreeneRGA-14 | Eli Lilly and Company Common Stock | Buy | Self | May 14, 2025 | May 19, 2025 | 5d | $1K – $15K | PDF ↗ |
Dan NewhouseRWA-4 | Eli Lilly and Company Common Stock | Partial sale | Spouse | Apr 11, 2025 | May 16, 2025 | 35d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | Apr 9, 2025 | May 14, 2025 | 35d | $1K – $15K | PDF ↗ |
Julie JohnsonDTX-32 | Eli Lilly and Company Common Stock | Sell | Joint | Apr 7, 2025 | May 14, 2025 | 37d | $1K – $15K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Eli Lilly and Company Common Stock | Buy | Joint | Apr 21, 2025 | May 13, 2025 | 22d | $15K – $50K | PDF ↗ |
Bruce WestermanRAR-4 | Eli Lilly and Company Common Stock | Sell | Self | Apr 21, 2025 | May 12, 2025 | 21d | $1K – $15K | PDF ↗ |
Marjorie Taylor GreeneRGA-14 | Eli Lilly and Company Common Stock | Buy | Self | May 5, 2025 | May 6, 2025 | 1d | $1K – $15K | PDF ↗ |
Eli Lilly and Company Common Stock | Sell | Self | Apr 8, 2025 | Apr 28, 2025 | 20d | $1K – $15K | PDF ↗ | |
Bruce WestermanRAR-4 | Eli Lilly and Company Common Stock | Buy | Self | Mar 3, 2025 | Apr 16, 2025 | 44d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | Mar 10, 2025 | Apr 10, 2025 | 31d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | Feb 19, 2025 | Mar 6, 2025 | 15d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | Jan 8, 2025 | Feb 10, 2025 | 33d | $1K – $15K | PDF ↗ |
Marjorie Taylor GreeneRGA-14 | Eli Lilly and Company Common Stock | Buy | Self | Jan 21, 2025 | Jan 27, 2025 | 6d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | Dec 18, 2024 | Jan 14, 2025 | 27d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | Dec 16, 2024 | Jan 14, 2025 | 29d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Eli Lilly and Company Common Stock | Partial sale | Joint | Dec 13, 2024 | Jan 14, 2025 | 32d | $1K – $15K | PDF ↗ |
How to read this data
- Members report dollar ranges, not exact amounts. Totals and flows use the midpoint of each range.
- The STOCK Act allows up to 45 days between a trade and its report. Delays past that are flagged with "!".
- Trades by a spouse or dependent child are included and labelled in the Owner column.
- Some filings exist only as scanned paper. Their trades are transcribed from the images and marked Scanned: they count in totals and flows, but not in performance scores.
- Handwritten paper filings cannot be read automatically and are not included yet. (241)
- Senate trades are not included yet.
- Public records shown for information only. Not investment advice.